Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2589_Библиотеки_им_академика_М_И_Перельмана
.pdf
References
https://t.me/medicina_free
259
adhesion molecule-1 in vitro. Immunol Cell Biol.
2012;90:912–5.
43. Oliver GF, Ferreira LB, Vieira BR, Arruda
S, Araújo M, Carr JM, Smith JR, Furtado
JM.Posterior segment ndings by spectral-domain
optical coherence tomography and clinical associations in active toxoplasmic retinochoroiditis.
Sci Rep. 2022;12(1):1156. https://doi.org/10.1038/
s41598- 022- 05070- 9. PMID: 35064148; PMCID:
PMC8782858.
44. Babu K, Shah D, Bhagya M, Murthy KR.Near full
thickness macular hole with an intact overlying
internal limiting membrane following resolution of
fulminant acquired toxoplasma retinitis—A unique
nding. Indian J Ophthalmol. 2020;68(1):244–6.
https://doi.org/10.4103/ijo.IJO_924_19. PMID:
31856540; PMCID: PMC6951158.
45. Dogra M, Singh SR. Commentary: internal limiting membrane sparing in necrotizing focal retinitis.
Indian J Ophthalmol. 2020;68(1):246–7. https://doi.
org/10.4103/ijo.IJO_2204_19. PMID: 31856541;
PMCID: PMC6951161.
46. Bosch-Driessen LE, Berendschot TT, Ongkosuwito
JV, Rothova A.Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology.
2002;109(5):869–78. https://doi.org/10.1016/s0161- -
6420(02)00990- 9. PMID: 11986090.
47. Elkins BS, Holland GN, Opremcak EM, Dunn JP Jr,
Jabs DA, Johnston WH, Green WR.Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy
in immunocompromised patients. Ophthalmology.
1994;101(3):499–507. https://doi.org/10.1016/
s0161- 6420(13)31267- 6. PMID: 8127570.
48. Silveira C, Vallochi AL, da Silva UR, Muccioli C,
Holland GN, Nussenblatt RB, Belfort R, Rizzo
LV. Toxoplasma gondii in the peripheral blood of
patients with acute and chronic toxoplasmosis. Br
J Ophthalmol. 2011;95(3):396–400. https://doi.
org/10.1136/bjo.2008.148205. Epub 2010 Jul 3.
PMID: 20601663.
49. Bourdin C, Busse A, Kouamou E, Touafek F, Bodaghi
B, Le Hoang P, Mazier D, Paris L, Fekkar A.PCRbased detection of Toxoplasma gondii DNA in blood
and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2014;52(11):3987–91.
https://doi.org/10.1128/JCM.01793- 14. Epub 2014
Sep 10. PMID: 25210066; PMCID: PMC4313235.
50. Silva MD, Teixeira C, Gomes P, Borges M.Promising
drug targets and compounds with anti-Toxoplasma
gondii activity. Microorganisms. 2021;9(9):1960.
https://doi.org/10.3390/microorganisms9091960.
PMID: 34576854; PMCID: PMC8471693.
51. Doggett JS, Schultz T, Miller AJ, Bruzual I, Pou
S, Winter R, Dodean R, Zakharov LN, Nilsen A,
Riscoe MK, Carruthers VB. Orally bioavailable
Endochin-like quinolone carbonate Ester prodrug
reduces Toxoplasma gondii brain cysts. Antimicrob
Agents Chemother. 2020;64(9):e00535–20. https://
doi.org/10.1128/AAC.00535- 20. PMID: 32540978;
PMCID: PMC7449172.
52. Sangaré LO, Ólafsson EB, Wang Y, Yang N, Julien
L, Camejo A, Pesavento P, Sidik SM, Lourido S,
Barragan A, Saeij JPJ.In vivo CRISPR screen identies TgWIP as a toxoplasma modulator of dendritic
cell migration. Cell Host Microbe. 2019;26(4):478–
492.e8. https://doi.org/10.1016/j.chom.2019.09.008.
PMID: 31600500; PMCID: PMC7060943.
53. Seizova S, Ruparel U, Garnham AL, Bader SM,
Uboldi AD, Coffey MJ, Whitehead LW, Rogers KL,
Tonkin CJ.Transcriptional modication of host cells
harboring Toxoplasma gondii bradyzoites prevents
IFN gamma-mediated cell death. Cell Host Microbe.
2022;30(2):232–247.e6. https://doi.org/10.1016/j.
chom.2021.11.012. Epub 2021 Dec 17. PMID:
34921775.
54. Caldas LA, de Souza W.A window to Toxoplasma
gondii Egress. Pathogens. 2018;7(3):69. https://doi.
org/10.3390/pathogens7030069. PMID: 30110938;
PMCID: PMC6161258.
55. Young NJ, Bird AC.Bilateral acute retinal necrosis.
Br J Ophthalmol. 1978;62(9):581–90. https://doi.
org/10.1136/bjo.62.9.581. PMID: 708676; PMCID:
PMC1043304.
56. Culbertson WW, Blumenkranz MS, Pepose JS,
Stewart JA, Curtin VT. Varicella zoster virus is
a cause of the acute retinal necrosis syndrome.
Ophthalmology. 1986;93(5):559–69. https://doi.
org/10.1016/s0161- 6420(86)33701- 1. PMID:
3014414.
57. Muthiah MN, Michaelides M, Child CS, Mitchell
SM. Acute retinal necrosis: a national populationbased study to assess the incidence, methods of
diagnosis, treatment strategies and outcomes in the
UK.Br J Ophthalmol. 2007;91(11):1452–5. https://
doi.org/10.1136/bjo.2007.114884. Epub 2007 May
15. PMID: 17504853; PMCID: PMC2095441.
58. Lau CH, Missotten T, Salzmann J, Lightman
SL. Acute retinal necrosis features, management,
and outcomes. Ophthalmology. 2007;114(4):756–
62. https://doi.org/10.1016/j.ophtha.2006.08.037.
Epub 2006 Dec 20. PMID: 17184841.
59. Holland GN.Standard diagnostic criteria for the acute
retinal necrosis syndrome. Executive Committee of
the American Uveitis Society. Am J Ophthalmol.
1994;117(5):663–7. https://doi.org/10.1016/s0002- -
9394(14)70075- 3. PMID: 8172275.
60. Standardization of Uveitis Nomenclature (SUN)
Working Group. Classication criteria for acute
retinal necrosis syndrome. Am J Ophthalmol.
2021;228:237–44. https://doi.org/10.1016/j.
ajo.2021.03.057. Epub 2021 Apr 15. PMID:
33845012; PMCID: PMC8675365.
61. Standardization of Uveitis Nomenclature (SUN)
Working Group. Classication criteria for
sarcoidosis- associated uveitis. Am J Ophthalmol.
2021;228:220–30. https://doi.org/10.1016/j.
ajo.2021.03.047. Epub 2021 May 11. PMID:
33845001; PMCID: PMC8594768.
62. Standardization of Uveitis Nomenclature (SUN)
Working Group. Classication criteria for cytomeg-
260
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
alovirus retinitis. Am J Ophthalmol. 2021;228:245–
54. https://doi.org/10.1016/j.ajo.2021.03.051.
Epub 2021 May 11. PMID: 33845015; PMCID:
PMC8594755.
63. Standardization of Uveitis Nomenclature (SUN)
Working Group. Classication criteria for Behçet
disease uveitis. Am J Ophthalmol. 2021;228:80–
8. https://doi.org/10.1016/j.ajo.2021.03.058.
Epub 2021 May 11. PMID: 33845008; PMCID:
PMC8545705.
64. Duker JS, Shakin EP. Rapidly progressive outer
retinal necrosis in the acquired immunodeciency
syndrome. Am J Ophthalmol. 1991;111(2):255–6.
https://doi.org/10.1016/s0002- 9394(14)72279- 2.
PMID: 1992756.
65. Forster DJ, Cano MR, Green RL, Rao
NA. Echographic features of the VogtKoyanagi- Harada syndrome. Arch Ophthalmol.
1990;108(10):1421–6. https://doi.org/10.1001/archo
pht.1990.01070120069031. PMID: 2222275.
66. Forster DJ, Dugel PU, Frangieh GT, Liggett PE,
Rao NA. Rapidly progressive outer retinal necrosis in the acquired immunodeciency syndrome.
Am J Ophthalmol. 1990;110(4):341–8. https://
doi.org/10.1016/s0002- 9394(14)77012- 6. PMID:
2220967.
67. Jabs DA, Schachat AP, Liss R, Knox DL, Michels
RG. Presumed varicella zoster retinitis in immunocompromised patients. Retina. 1987;7(1):9–13.
PMID: 3602608.
68. Lei B, Zhou M, Wang Z, Chang Q, Xu G, Jiang
R.Ultra-wide-field fundus imaging of acute retinal necrosis: clinical characteristics and visual
significance. Eye (Lond). 2020;34(5):864–72.
https://doi.org/10.1038/s41433- 019- 0587- 8.
Epub 2019 Sep 25. PMID: 31554945; PMCID:
PMC7182555.
69. Zhao XY, Meng LH, Zhang WF, Wang DY, Chen
YX. Retinal detachment after acute retinal necrosis and the efcacies of different interventions:
a systematic review and metaanalysis. Retina.
2021;41(5):965–78. https://doi.org/10.1097/
IAE.0000000000002971. PMID: 32932382.
70. Meghpara B, Sulkowski G, Kesen MR, Tessler HH,
Goldstein DA.Long-term follow-up of acute retinal necrosis. Retina. 2010;30(5):795–800. https://
doi.org/10.1097/IAE.0b013e3181c7013c. PMID:
20057342.
71. Fan S, Lin D, Wang Y. Role of prophylactic vitrectomy in acute retinal necrosis in preventing
rhegmatogenous retinal detachment: systematic
review and meta-analysis. Ocul Immunol Inamm.
2022;30(2):515–9. https://doi.org/10.1080/0927
3948.2020.1800051. Epub 2020 Sep 23. PMID:
32966153.
72. Miserocchi E, Iuliano L, Fogliato G, Modorati G,
Couto C, Schlaen A, Hurtado E, Llorenç V, Adan A,
Bandello F.Bilateral acute retinal necrosis: clinical
features and outcomes in a multicenter study. Ocul
Immunol Inamm. 2019;27(7):1090–8. https://doi.
org/10.1080/09273948.2018.1501494. Epub 2018
Jul 30. PMID: 30059636.
73. Yawn BP, Wollan PC, Kurland MJ, St Sauver
JL, Saddier P. Herpes zoster recurrences more
frequent than previously reported. Mayo Clin
Proc. 2011;86(2):88–93. https://doi.org/10.4065/
mcp.2010.0618. Epub 2011 Jan 10. PMID:
21220354; PMCID: PMC3031432.
74. Kobayashi T, Sekar P, Meier J, Streit J. Acute
retinal necrosis in a patient with remote severe
herpes simplex encephalitis. BMJ Case Rep.
2019;12(5):e229137. https://doi.org/10.1136/
bcr- 2018- 229137. PMID: 31138593; PMCID:
PMC6557359.
75. Todokoro D, Kamei S, Goto H, Ikeda Y, Koyama H,
Akiyama H.Acute retinal necrosis following herpes
simplex encephalitis: a nationwide survey in Japan.
Jpn J Ophthalmol. 2019;63(4):304–9. https://doi.
org/10.1007/s10384- 019- 00668- 5. Epub 2019 May
3. PMID: 31054049.
76. Klein A, Lefebvre P. Three consecutive episodes
of acute retinal necrosis due to herpes simplex-1
over twelve years following herpetic encephalitis.
Ocul Immunol Inamm. 2007;15(5):411–3. https://
doi.org/10.1080/09273940701662510. PMID:
17972228.
77. Kim SJ, Kang SW, Joo EY. An unusual case of
herpes simplex viral encephalitis following acute
retinal necrosis after administration of a systemic
steroid. J Epilepsy Res. 2012;2(1):21–4. https://doi.
org/10.14581/jer.12006. PMID: 24649457; PMCID:
PMC3952316.
78. Matsuo T, Nakayama T, Baba T. Same eye recurrence of acute retinal necrosis syndrome. Am J
Ophthalmol. 2001;131(5):659–61. https://doi.
org/10.1016/s0002- 9394(00)00847- 3. PMID:
11336947.
79. Donovan CP, Levison AL, Lowder CY, Martin
DF, Srivastava SK. Delayed recurrence of acute
retinal necrosis (ARN): a case series. J Clin
Virol. 2016;80:68–71. https://doi.org/10.1016/j.
jcv.2016.04.021. Epub 2016 Apr 30. PMID:
27179886.
80. Okunuki Y, Usui Y, Kezuka T, Takeuchi M, Goto
H. Four cases of bilateral acute retinal necrosis with a long interval after the initial onset. Br
J Ophthalmol. 2011;95(9):1251–4. https://doi.
org/10.1136/bjo.2010.191288. Epub 2011 Jan 17.
PMID: 21242577.
81. Grinde B.Herpesviruses: latency and reactivation—
viral strategies and host response. J Oral Microbiol.
2013;5. https://doi.org/10.3402/jom.v5i0.22766.
PMID: 24167660; PMCID: PMC3809354.
82. Cohen JI. Herpesvirus latency. J Clin Invest.
2020;130(7):3361–9. https://doi.org/10.1172/
JCI136225. PMID: 32364538; PMCID:
PMC7324166.
83. Pirofski LA, Casadevall A. The state of latency
in microbial pathogenesis. J Clin Invest.
2020;130(9):4525–31. https://doi.org/10.1172/
References
https://t.me/medicina_free
261
JCI136221. PMID: 32804154; PMCID:
PMC7456213.
84. Wang K, Hoshino Y, Dowdell K, Bosch-Marce M,
Myers TG, Sarmiento M, Pesnicak L, Krause PR,
Cohen JI. Glutamine supplementation suppresses
herpes simplex virus reactivation. J Clin Invest.
2017;127(7):2626–30. https://doi.org/10.1172/
JCI88990. Epub 2017 Jun 5. PMID: 28581445;
PMCID: PMC5490748.
85. Hoover DR, Peng Y, Saah A, Semba R, Detels RR,
Rinaldo CR Jr, Phair JP. Occurrence of cytomegalovirus retinitis after human immunodeciency
virus immunosuppression. Arch Ophthalmol.
1996;114(7):821–7. https://doi.org/10.1001/archo
pht.1996.01100140035004. PMID: 8660165.
86. Downes KM, Tarasewicz D, Weisberg LJ,
Cunningham ET Jr. Good syndrome and other
causes of cytomegalovirus retinitis in HIV-negative
patients—case report and comprehensive review
of the literature. J Ophthalmic Inamm Infect.
2016;6(1):3. https://doi.org/10.1186/s12348- 016-
0070- 7. Epub 2016 Jan 25. PMID: 26809342;
PMCID: PMC4726639.
87. Davis JL, Haft P, Hartley K.Retinal arteriolar occlusions due to cytomegalovirus retinitis in elderly
patients without HIV.J Ophthalmic Inamm Infect.
2013;3(1):17. https://doi.org/10.1186/1869- 5760-
3- 17. PMID: 23514532; PMCID: PMC3605088.
88. Pathanapitoon K, Tesavibul N, Choopong P,
Boonsopon S, Kongyai N, Ausayakhun S,
Kunavisarut P, Rothova A.Clinical manifestations
of cytomegalovirus-associated posterior uveitis
and panuveitis in patients without human immunodeciency virus infection. JAMA Ophthalmol.
2013;131(5):638–45. https://doi.org/10.1001/
jamaophthalmol.2013.2860. PMID: 23494002.
89. Shapira Y, Mimouni M, Vishnevskia-Dai
V. Cytomegalovirus retinitis in HIV-negative
patients—associated conditions, clinical presentation, diagnostic methods and treatment strategy.
Acta Ophthalmol. 2018;96(7):e761–7. https://doi.
org/10.1111/aos.13553. Epub 2017 Oct 25. PMID:
29068151.
90. Gupta S, Vemulakonda GA, Suhler EB, Yeh S, Albini
TA, Mandelcorn E, Flaxel CJ. Cytomegalovirus
retinitis in the absence of AIDS.Can J Ophthalmol.
2013;48(2):126–9. https://doi.org/10.1016/j.
jcjo.2012.12.002. PMID: 23561607.
91. Schneider EW, Elner SG, van Kuijk FJ, Goldberg
N, Lieberman RM, Eliott D, Johnson MW.Chronic
retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in nonHIV patients. Retina. 2013;33(9):1791–9. https://
doi.org/10.1097/IAE.0b013e318285f486. PMID:
23584702.
92. Invernizzi A, Agarwal A, Ravera V, Oldani M,
Staurenghi G, Viola F.Optical coherence tomography ndings in cytomegalovirus retinitis: a longitudinal study. Retina. 2018;38(1):108–17. https://
doi.org/10.1097/IAE.0000000000001503. PMID:
28145973.
93. Invernizzi A, Agarwal AK, Ravera V, Mapelli
C, Riva A, Staurenghi G, McCluskey PJ, Viola
F. Comparing optical coherence tomography ndings in different aetiologies of infectious necrotising retinitis. Br J Ophthalmol. 2018;102(4):433–7.
https://doi.org/10.1136/bjophthalmol- 2017- 310210.
Epub 2017 Aug 1. PMID: 28765144.
94. Rao NA, Zhang J, Ishimoto S.Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Am Ophthalmol Soc. 1998;96:111–23;
discussion 124–6. PMID: 10360285; PMCID:
PMC1298391.
95. Martin DF, Sierra-Madero J, Walmsley S, Wolitz
RA, Macey K, Georgiou P, Robinson CA, Stempien
MJ, Valganciclovir Study Group. A controlled trial
of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med. 2002;346(15):1119–
26. https://doi.org/10.1056/NEJMoa011759.
Erratum in: N Engl J Med 2002 Sep 12;347(11):862.
PMID: 11948271.
96. Agarwal A, Kumari N, Trehan A, Khadwal A, Dogra
MR, Gupta V, Sharma A, Gupta A, Singh R.Outcome
of cytomegalovirus retinitis in immunocompromised
patients without human immunodeciency virus
treated with intravitreal ganciclovir injection. Graefes
Arch Clin Exp Ophthalmol. 2014;252(9):1393–401.
https://doi.org/10.1007/s00417- 014- 2587- 5. Epub
2014 Feb 21. PMID: 24557658.
97. Royston L, Royston E, Masouridi-Levrat S,
Vernaz N, Chalandon Y, Van Delden C, Neofytos
D. Letermovir primary prophylaxis in high-risk
hematopoietic cell transplant recipients: a matched
cohort study. Vaccines (Basel). 2021;9(4):372.
https://doi.org/10.3390/vaccines9040372. PMID:
33921218; PMCID: PMC8069238.
98. Port AD, Orlin A, Kiss S, Patel S, D’Amico DJ,
Gupta MP. Cytomegalovirus retinitis: a review. J
Ocul Pharmacol Ther. 2017;33(4):224–34. https://
doi.org/10.1089/jop.2016.0140. Epub 2017 Mar 29.
PMID: 28355091.
99. Gupta A, Sharma A, Bansal R, Sharma
K. Classication of intraocular tuberculosis. Ocul
Immunol Inamm. 2015;23(1):7–13. https://doi.org/
10.3109/09273948.2014.967358. Epub 2014 Oct 14.
PMID: 25314361.
100. Gupta MP, Coombs P, Prockop SE, Hasan AA,
Doubrovina E, O’Reilly RJ, Cohen SH, Park SS,
Kiss S. Treatment of cytomegalovirus retinitis
with cytomegalovirus-specic T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina.
2015;46(1):80–2. https://doi.org/10.3928/23258160- -
20150101- 14. PMID: 25559515; PMCID:
PMC4373317.
101. Pepple KL, Van Gelder RN. T-cell therapy to the
rescue. Ophthalmol Retina. 2021;5(9):835–7.
https://doi.org/10.1016/j.oret.2021.07.001. PMID:
34503757.
262
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
102. Seo S, Smith C, Fraser C, Patheja R, Shah SP, Rehan
S, Crooks P, Neller MA, Khanna R.Adoptive T-cell
therapy for pediatric cytomegalovirus-associated
retinitis. Blood Adv. 2019;3(11):1774–7. https://doi.
org/10.1182/bloodadvances.2019000121. PMID:
31186253; PMCID: PMC6560354.
103. Kuthyar S, Anthony CL, Fashina T, Yeh S, Shantha
JG.World Health Organization high priority pathogens: ophthalmic disease ndings and vision health
perspectives. Pathogens. 2021;10(4):442. https://doi.
org/10.3390/pathogens10040442. PMID: 33917710;
PMCID: PMC8068131.
104. Babu K, Kini R, Philips M, Subbakrishna
DK.Clinical prole of isolated viral anterior uveitis
in a south Indian patient population. Ocul Immunol
Inamm. 2014;22(5):356–9. https://doi.org/10.3109
/09273948.2013.841482. Epub 2013 Oct 10. PMID:
24111839.
105. Mahendradas P, Shetty R, Malathi J, Madhavan
HN. Chikungunya virus iridocyclitis in Fuchs’
heterochromic iridocyclitis. Indian J Ophthalmol.
2010;58(6):545–7. https://doi.org/10.4103/0301-
4738.71707. PMID: 20952847; PMCID:
PMC2993993.
106. Ryan FJ, Carr JM, Furtado JM, Ma Y, Ashander
LM, Simões M, Oliver GF, Granado GB, Dawson
AC, Michael MZ, Appukuttan B, Lynn DJ, Smith
JR. Zika virus infection of human iris pigment
epithelial cells. Front Immunol. 2021;12:644153.
https://doi.org/10.3389/mmu.2021.644153. PMID:
33968035; PMCID: PMC8100333.
107. Furtado JM, Espósito DL, Klein TM, Teixeira-Pinto
T, da Fonseca BA.Uveitis associated with Zika virus
infection. N Engl J Med. 2016;375(4):394–6. https://
doi.org/10.1056/NEJMc1603618. Epub 2016 Jun
22. PMID: 27332784.
108. Troumani Y, Touhami S, Jackson TL, Ventura
CV, Stanescu-Segall DM, Errera MH, Rousset
D, Bodaghi B, Cartry G, David T, Beral
L.Association of anterior uveitis with acute Zika
virus infection in adults. JAMA Ophthalmol.
2021;139(1):95–102. https://doi.org/10.1001/
jamaophthalmol.2020.5131. PMID: 33237306;
PMCID: PMC7689574.
109. Abroug N, Khairallah M, Zina S, Ksiaa I, Amor HB,
Attia S, Jelliti B, Khochtali S, Khairallah M.Ocular
manifestations of emerging arthropod-borne infectious diseases. J Curr Ophthalmol. 2021;33(3):227–
35. https://doi.org/10.4103/joco.joco_134_21.
PMID: 34765808; PMCID: PMC8579803.
110. Pattnaik A, Sahoo BR, Pattnaik AK. Current status of Zika virus vaccines: successes and challenges. Vaccines (Basel). 2020;8(2):266. https://doi.
org/10.3390/vaccines8020266. PMID: 32486368;
PMCID: PMC7349928.
111. Wolgemuth CW.Flagellar motility of the pathogenic
spirochetes. Semin Cell Dev Biol. 2015;46:104–12.
https://doi.org/10.1016/j.semcdb.2015.10.015.
Epub 2015 Oct 17. PMID: 26481969; PMCID:
PMC4994469.
112. Furtado JM, Simões M, Vasconcelos-Santos D,
Oliver GF, Tyagi M, Nascimento H, Gordon DL,
Smith JR. Ocular syphilis. Surv Ophthalmol.
2022;67(2):440–62. https://doi.org/10.1016/j.survo-
phthal.2021.06.003. S0039-6257(21)00140–5. Epub
ahead of print. PMID: 34147542.
113. Caplash S, Gangaputra S, Kesav N, Akanda M,
Vitale S, Kodati S, Marques A, Sen HN.Usefulness
of routine Lyme screening in patients with uveitis.
Ophthalmology. 2019;126(12):1726–8. https://doi.
org/10.1016/j.ophtha.2019.06.014. Epub 2019 Jun
27. PMID: 31358389; PMCID: PMC6875618.
114. Chu KM, Rathinam R, Namperumalsamy P,
Dean D. Identication of Leptospira species in
the pathogenesis of uveitis and determination
of clinical ocular characteristics in South India.
J Infect Dis. 1998;177(5):1314–21. https://doi.
org/10.1086/515273. PMID: 9593018.
115. Rathinam SR. Leptospirosis. In: Chee SP,
Khairallah M, editors. Emerging infectious
uveitis. Cham: Springer; 2017. https://doi.
org/10.1007/978- 3- 319- 23416- 8_8.
116. Oast SP.Concerning tuberculous lesions of the retina. Trans Am Ophthalmol Soc. 1932;30:503–27.
PMID: 16692952; PMCID: PMC1316870.
117. Duke-Elder S, Perkins ES, editors. System of ophthalmology, diseases of the uvea, vol. IX. Henry
Kimpton: London; 1966. p.246–81.
118. Duke-Elder S, Perkins ES.System of ophthalmology, diseases of the uvea, vol. IX.London: Henry
Kimpton; 1966. p.574.
119. Wilder HC. Toxoplasma chorioretinitis in adults.
AMA Arch Ophthalmol. 1952;48(2):127–36. https://
doi.org/10.1001/archopht.1952.00920010132001.
PMID: 14943320.
120. Zimmerman LE. Verhoeff’s “terato-neuroma” a
critical reappraisal in light of new observations and
current concepts of embryonic tumors. Trans Am
Ophthalmol Soc. 1971;69:210–36. PMID: 4116382;
PMCID: PMC1310415.
121. Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki
O, Brazitikou I, Kalogeropoulos C, Androudi S.A
focus on the epidemiology of uveitis. Ocul Immunol
Inamm. 2018;26(1):2–16. https://doi.org/10.1080/
09273948.2016.1196713. Epub 2016 Jul 28. PMID:
27467180.
122. Gupta A, Gupta V, Arora S, Dogra MR,
Bambery P. PCR-positive tubercular retinal
vasculitis: clinical characteristics and management. Retina. 2001;21(5):435–44. https://doi.
org/10.1097/00006982- 200110000- 00004. PMID:
11642371.
123. Gupta V, Arora S, Gupta A, Ram J, Bambery
P, Sehgal S. Management of presumed intraocular tuberculosis: possible role of the polymerase chain reaction. Acta Ophthalmol Scand.
1998;76(6):679–82. https://doi.org/10.1034/j.1600- -
0420.1998.760609.x. PMID: 9881551.
124. Gupta V, Gupta A, Bambery P, Radotra BD, Pandav
SS. Vogt-Koyanagi-Harada syndrome follow-
References
https://t.me/medicina_free
263
ing injury-induced progressive vitiligo. Indian J
Ophthalmol. 2001;49:53–5.
125. Gupta V, Gupta A, Sachdeva N, Arora S, Bambery
P. Successful management of tubercular subretinal
granulomas. Ocul Immunol Inamm. 2006;14(1):35–
40. https://doi.org/10.1080/09273940500269939.
PMID: 16507489.
126. Alli HD, Ally N, Mayet I, Dangor Z, Madhi
SA. Global prevalence and clinical outcomes of
tubercular uveitis: a systematic review and metaanalysis. Surv Ophthalmol. 2022;67(3):770–92.
https://doi.org/10.1016/j.survophthal.2021.10.001.
Epub 2021 Oct 7. PMID: 34626620.
127. Gupta V, Gupta A, Arora S, Bambery P, Dogra
MR, Agarwal A.Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology. 2003;110(9):1744–9. https://
doi.org/10.1016/S0161- 6420(03)00619- 5. PMID:
13129872.
128. Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A,
Bambery P. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis.
Ophthalmology. 2012;119(11):2334–42. https://doi.
org/10.1016/j.ophtha.2012.05.034. Epub 2012 Aug
11. PMID: 22892153.
129. Gupta A, Bansal R, Gupta V, Sharma A. Fundus
autouorescence in serpiginouslike choroiditis.
Retina. 2012;32(4):814–25. https://doi.org/10.1097/
IAE.0b013e3182278c41. PMID: 22080913.
130. Gupta V, Bansal R, Gupta A.Continuous progression of tubercular serpiginous-like choroiditis
after initiating antituberculosis treatment. Am J
Ophthalmol. 2011;152(5):857–63.e2. https://doi.
org/10.1016/j.ajo.2011.05.004. Epub 2011 Jul 26.
PMID: 21794847.
131. Aggarwal K, Agarwal A, Deokar A, Singh R,
Bansal R, Sharma A, Sharma K, Dogra MR, Gupta
V.Ultra-wide eld imaging in paradoxical worsening of tubercular multifocal Serpiginoid choroiditis
after the initiation of anti-tubercular therapy. Ocul
Immunol Inamm. 2019;27(3):365–70. https://doi.
org/10.1080/09273948.2017.1373829. Epub 2017
Oct 11. PMID: 29020501.
132. Agarwal A, Aggarwal K, Mandadi SKR, Kumar
A, Grewal D, Invernizzi A, Bansal R, Sharma
A, Sharma K, Gupta V, for OCTA Study Group.
Longitudinal follow-up of tubercular serpiginouslike choroiditis using optical coherence tomography
angiography. Retina. 2021;41(4):793–803. https://
doi.org/10.1097/IAE.0000000000002915. PMID:
32833411.
133. Agarwal A, Aggarwal K, Pichi F, Meng T, Munk MR,
Bazgain K, Bansal R, Agrawal R, Gupta V.Clinical
and multimodal imaging clues in differentiating
between tuberculomas and sarcoid choroidal granulomas. Am J Ophthalmol. 2021;226:42–55. https://
doi.org/10.1016/j.ajo.2021.01.025. Epub 2021 Jan
30. PMID: 33529591.
134. Agarwal A, Freund KB, Kumar A, Aggarwal K,
Sharma D, Katoch D, Bansal R, Gupta V, OCTA
Study Group. Bacillary layer detachment in acute
Vogt-Koyanagi-Harada disease: a novel sweptsource optical coherence tomography analysis.
Retina. 2021;41(4):774–83. https://doi.org/10.1097/
IAE.0000000000002914. PMID: 32833410.
135. Barondes MJ, Sponsel WE, Stevens TS, Plotnik
RD. Tuberculous choroiditis diagnosed by
chorioretinal endobiopsy. Am J Ophthalmol.
1991;112(4):460–1. https://doi.org/10.1016/s0002- -
9394(14)76260- 9. PMID: 1928253.
136. Rao NA, Saraswathy S, Smith RE.Tuberculous uveitis: distribution of Mycobacterium tuberculosis in
the retinal pigment epithelium. Arch Ophthalmol.
2006;124(12):1777–9. https://doi.org/10.1001/
archopht.124.12.1777. PMID: 17159041.
137. Kawali A, Emerson GG, Naik NK, Sharma K,
Mahendradas P, Rao NA. Clinicopathologic features of Tuberculous serpiginous-like choroiditis.
JAMA Ophthalmol. 2018;136(2):219–21. https://
doi.org/10.1001/jamaophthalmol.2017.5791. PMID:
29270629.
138. Bansal R, Sharma K, Gupta A, Sharma A, Singh
MP, Gupta V, Mulkutkar S, Dogra M, Dogra MR,
Kamal S, Sharma SP, Fiorella PD. Detection of
Mycobacterium tuberculosis genome in vitreous
uid of eyes with multifocal serpiginoid choroiditis.
Ophthalmology. 2015;122(4):840–50. https://doi.
org/10.1016/j.ophtha.2014.11.021. Epub 2015 Jan
9. PMID: 25578256.
139. Nazari Khanamiri H, Rao NA.Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.
Surv Ophthalmol. 2013;58(3):203–32. https://doi.
org/10.1016/j.survophthal.2012.08.008. Epub 2013
Mar 27. PMID: 23541041; PMCID: PMC3631461.
140. Song JH, Koreishi AF, Goldstein DA.Tuberculous
uveitis presenting with a bullous exudative retinal
detachment: a case report and systematic literature
review. Ocul Immunol Inamm. 2019;27(6):998–
1009. https://doi.org/10.1080/09273948.2018.1485
958. Epub 2018 Jul 3. PMID: 29969330.
141. Datta M, Via LE, Kamoun WS, Liu C, Chen W,
Seano G, Weiner DM, Schimel D, England K,
Martin JD, Gao X, Xu L, Barry CE 3rd, Jain
RK. Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature
and improves small molecule delivery. Proc Natl
Acad Sci U S A. 2015;112(6):1827–32. https://doi.
org/10.1073/pnas.1424563112. Epub 2015 Jan 26.
PMID: 25624495; PMCID: PMC4330784.
142. Hortle E, Oehlers SH.Host-directed therapies targeting the tuberculosis granuloma stroma. Pathog
Dis. 2020;78(2):ftaa015. https://doi.org/10.1093/
femspd/ftaa015. PMID: 32149337.
143. Oehlers SH.Revisiting hypoxia therapies for tuberculosis. Clin Sci (Lond). 2019;133(12):1271–80.
https://doi.org/10.1042/CS20190415. PMID:
31209098.
144. Babu K, Murthy PR, Murthy KR.Intravitreal bevacizumab as an adjunct in a patient with presumed
vascularised choroidal tubercular granuloma. Eye
264
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
(Lond). 2010;24(2):397–9. https://doi.org/10.1038/
eye.2009.83. Epub 2009 Apr 17. PMID: 19373263.
145. Bansal R, Beke N, Sharma A, Gupta A.Intravitreal
bevacizumab as an adjunct in the management of
a vascular choroidal granuloma. BMJ Case Rep.
2013;2013:bcr2013200255. https://doi.org/10.1136/
bcr- 2013- 200255. PMID: 24014333; PMCID:
PMC3794147.
146. Agarwal M, Gupta C, Mohan KV, Upadhyay PK, Jha
V.Correlation of vascular endothelial growth factor
with the clinical regression of tubercular granuloma. Indian J Ophthalmol. 2020;68(9):2037–40.
https://doi.org/10.4103/ijo.IJO_1261_20. PMID:
32823472; PMCID: PMC7690512.
147. Sharma K, Bansal R, Sharma A, Gupta A, Fiorella
PD. Successful treatment of rifampicin-resistant
intraocular tuberculosis. Ocul Immunol Inamm.
2015;23(1):93–6. https://doi.org/10.3109/09273948.
2014.888084. Epub 2014 Mar 21. PMID: 24654625.
148. Sharma K, Gupta A, Sharma M, Sharma A, Bansal
R, Sharma SP, Singh RD, Gupta V. The emerging
challenge of diagnosing drug-resistant tubercular
uveitis: experience of 110 eyes from North India.
Ocul Immunol Inamm. 2021;29(1):107–14. https://
doi.org/10.1080/09273948.2019.1655581. Epub
ahead of print. PMID: 31580170.
149. Sharma K, Sharma A, Bansal R, Fiorella PD,
Gupta A. Drug-resistant tubercular uveitis. J
Clin Microbiol. 2014;52(11):4113–4. https://doi.
org/10.1128/JCM.01918- 14. Epub 2014 Sep 3.
PMID: 25187635; PMCID: PMC4313252.
150. Biswas J, Ravi RK, Naryanasamy A, Kulandai LT,
Madhavan HN.Eales’ disease—current concepts in
diagnosis and management. J Ophthalmic Inamm
Infect. 2013;3(1):11. https://doi.org/10.1186/1869- -
5760- 3- 11. PMID: 23514227; PMCID:
PMC3605068.
151. Singh R, Toor P, Parchand S, Sharma K, Gupta V,
Gupta A. Quantitative polymerase chain reaction
for Mycobacterium tuberculosis in so-called Eales’
disease. Ocul Immunol Inamm. 2012;20(3):153–7.
https://doi.org/10.3109/09273948.2012.658134.
Epub 2012 Apr 9. PMID: 22486260.
152. Madhavan HN, Therese KL, Kavitha D. Further
investigations on the association of Mycobacterium
tuberculosis with Eales’ disease. Indian J
Ophthalmol. 2002;50:35–9.
153. Bodaghi B, Rozenberg F, Cassoux N, Fardeau C,
LeHoang P. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis.
Ophthalmology. 2003;110(9):1737–43. https://
doi.org/10.1016/S0161- 6420(03)00580- 3. PMID:
13129871.
154. Biswas J, Mayr AJ, Martin WJ, Rao NA.Detection
of human cytomegalovirus in ocular tissue by
polymerase chain reaction and in situ hybridization. Graefes Arch Clin Exp Ophthalmol.
1993;231:66–70.
155. Fenner TE, Garweg J, Hufert FT, Boehnke M,
Schmitz H. Diagnosis of human cytomegalovirus-
induced retinitis in human immunodeciency
virus type 1-infected subjects by using the
polymerase chain reaction. J Clin Microbiol.
1991;29(11):2621–2. https://doi.org/10.1128/
JCM.29.11.2621- 2622.1991. PMID: 1663513;
PMCID: PMC270387.
156. Fox GM, Crouse CA, Chuang EL, Pugfelder SC,
Cleary TJ, Nelson SJ, Atherton SS.Detection of herpesvirus DNA in vitreous and aqueous specimens
by the polymerase chain reaction. Arch Ophthalmol.
1991;109(2):266–71. https://doi.org/10.1001/archo
pht.1991.01080020112054. PMID: 1847043.
157. Knox CM, Chandler D, Short GA, Margolis
TP. Polymerase chain reaction-based assays
of vitreous samples for the diagnosis of
viral retinitis. Use in diagnostic dilemmas.
Ophthalmology. 1998;105(1):37–44; discussion
44–5. PMID: 9442777. https://doi.org/10.1016/
s0161- 6420(98)71127- 2.
158. McCann JD, Margolis TP, Wong MG, Kuppermann
BD, Luckie AP, Schwartz DM, Irvine AR, Ai E. A
sensitive and specic polymerase chain reactionbased assay for the diagnosis of cytomegalovirus
retinitis. Am J Ophthalmol. 1995;120(2):219–26.
https://doi.org/10.1016/s0002- 9394(14)72610- 8.
PMID: 7639306.
159. Montoya JG, Parmley S, Liesenfeld O, Jaffe
GJ, Remington JS. Use of the polymerase chain
reaction for diagnosis of ocular toxoplasmosis.
Ophthalmology. 1999;106(8):1554–63. https://
doi.org/10.1016/S0161- 6420(99)90453- 0. PMID:
10442904.
160. Nishi M, Hanashiro R, Mori S, Masuda K,
Mochizuki M, Hondo R. Polymerase chain reaction for the detection of the varicella-zoster genome
in ocular samples from patients with acute retinal
necrosis. Am J Ophthalmol. 1992;114(5):603–9.
https://doi.org/10.1016/s0002- 9394(14)74491- 5.
PMID: 1332482.
161. Short GA, Margolis TP, Kuppermann BD, Irvine
AR, Martin DF, Chandler D. A polymerase chain
reaction-based assay for diagnosing varicellazoster virus retinitis in patients with acquired
immunodeciency syndrome. Am J Ophthalmol.
1997;123(2):157–64. https://doi.org/10.1016/s0002- -
9394(14)71031- 1. PMID: 9186120.
162. Varkey JB, Shantha JG, Crozier I, Kraft CS,
Lyon GM, Mehta AK, Kumar G, Smith JR,
Kainulainen MH, Whitmer S, Ströher U, Uyeki
TM, Ribner BS, Yeh S.Persistence of Ebola virus
in ocular uid during convalescence. N Engl J Med.
2015;372(25):2423–7. https://doi.org/10.1056/
NEJMoa1500306. Epub 2015 May 7. Erratum in:
N Engl J Med 2015 Jun 18;372(25):2469. PMID:
25950269; PMCID: PMC4547451.
163. Nakano S, Tomaru Y, Kubota T, Takase H,
Mochizuki M, Shimizu N, Sugita S, Strip PCR
Project Group. Evaluation of a multiplex strip PCR
test for infectious uveitis: a prospective multicenter
study. Am J Ophthalmol. 2020;213:252–9. https://
References
https://t.me/medicina_free
265
doi.org/10.1016/j.ajo.2019.10.031. Epub 2019 Nov
28. PMID: 31785234.
164. Sharma K, Gupta V, Bansal R, Sharma A, Sharma
M, Gupta A.Novel multi-targeted polymerase chain
reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inamm Infect. 2013;3(1):25.
https://doi.org/10.1186/1869- 5760- 3- 25. PMID:
23514226; PMCID: PMC3605072.
165. Therese KL, Jayanthi U, Madhavan HN.Application
of nested polymerase chain reaction (nPCR) using
MPB 64 gene primers to detect Mycobacterium
tuberculosis DNA in clinical specimens from extrapulmonary tuberculosis patients. Indian J Med Res.
2005;122(2):165–70. PMID: 16177475.
166. Sharma K, Gupta A, Sharma M, Singh S, Sharma
A, Singh R, Gupta V. Detection of viable
Mycobacterium tuberculosis in ocular uids using
mRNA-based multiplex polymerase chain reaction.
Indian J Med Microbiol. 2022;40(2):254–7. https://
doi.org/10.1016/j.ijmmb.2021.12.019. Epub 2022
Jan 17. PMID: 35058073.
167. Bansal R, Gupta A, Gupta V, Mulkutkar S, Dogra
M, Katoch D, Dogra MR, Sharma K, Singh MP,
Sharma A, Kamal S, Sharma SP.Safety and outcome
of microincision vitreous surgery in uveitis. Ocul
Immunol Inamm. 2017;25(6):775–84. https://doi.
org/10.3109/09273948.2016.1165259. Epub 2016
May 18. PMID: 27191861.
168. Zhao XY, Xia S, Chen YX.Role of diagnostic pars
plana vitrectomy in determining the etiology of uveitis initially unknown. Retina. 2020;40(2):359–69.
https://doi.org/10.1097/IAE.0000000000002372.
PMID: 31972807.
169. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl
Acad Sci U S A. 1977;74(12):5463–7. https://doi.
org/10.1073/pnas.74.12.5463. PMID: 271968;
PMCID: PMC431765.
170. Gu W, Miller S, Chiu CY. Clinical metagenomic
next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14:319–38. https://doi.
org/10.1146/annurev- pathmechdis- 012418- 012751.
Epub 2018 Oct 24. PMID: 30355154; PMCID:
PMC6345613.
171. Deshmukh D, Joseph J, Chakrabarti M, Sharma
S, Jayasudha R, Sama KC, Sontam B, Tyagi M,
Narayanan R, Shivaji S.New insights into culture
negative endophthalmitis by unbiased next generation sequencing. Sci Rep. 2019;9(1):844. https://
doi.org/10.1038/s41598- 018- 37502- w. PMID:
30696908; PMCID: PMC6351655.2416-4. PMID:
29515160; PMCID: PMC5841358.
172. Valdes L, Bispo P, Sobrin L.Application of metagenomic sequencing in the diagnosis of infectious
uveitis. Semin Ophthalmol. 2020;35(5–6):276–9.
https://doi.org/10.1080/08820538.2020.1818795.
Epub 2020 Oct 18. PMID: 33073643.
173. Doan T, Sahoo MK, Ruder K, Huang C, Zhong
L, Chen C, Hinterwirth A, Lin C, Gonzales JA,
Pinsky BA, Acharya NR. Comprehensive patho-
gen detection for ocular infections. J Clin Virol.
2021;136:104759. https://doi.org/10.1016/j.
jcv.2021.104759. Epub 2021 Feb 11. PMID:
33609933; PMCID: PMC7954984.
174. Gonzales JA, Doan T, VanZante A, Stewart JM, Sura
A, Reddy A, Rasool N.Detection of Tropheryma
whipplei genome from the aqueous humor by
metagenomic sequencing. Ann Intern Med.
2021;174(9):1329–30. https://doi.org/10.7326/L20- -
1470. Epub 2021 Jun 15. PMID: 34125575.
175. Arunasri K, Mahesh M, Sai Prashanthi G, Jayasudha
R, Kalyana Chakravarthy S, Tyagi M, Pappuru RR,
Shivaji S.Comparison of the vitreous uid bacterial microbiomes between individuals with post
fever retinitis and healthy controls. Microorganisms.
2020;8(5):751. https://doi.org/10.3390/micro-
organisms8050751. PMID: 32429503; PMCID:
PMC7285296.
176. Phadke VK, Shantha JG, O’Keefe G. Relapsing
uveitis due to human T-lymphotropic virus type
1in a patient living with HIV diagnosed by metagenomic deep sequencing. Open Forum Infect Dis.
2020;7(3):ofaa078. https://doi.org/10.1093/od/
ofaa078. PMID: 32206676; PMCID: PMC7081385.
177. D'Cruz DP, Khamashta MA, Hughes
GR. Systemic lupus erythematosus. Lancet.
2007;369(9561):587–96. https://doi.org/10.1016/
S0140- 6736(07)60279- 7. PMID: 17307106.
178. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman
A. Fifty years of anti-ds DNA antibodies: are we
approaching journey’s end? Rheumatology (Oxford).
2007;46(7):1052–6. https://doi.org/10.1093/rheu-
matology/kem112. Epub 2007 May 11. PMID:
17500073.
179. Rahman A, Isenberg DA.Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929–39. https://
doi.org/10.1056/NEJMra071297. PMID: 18305268.
180. Dammacco R. Systemic lupus erythematosus and
ocular involvement: an overview. Clin Exp Med.
2018;18(2):135–49. https://doi.org/10.1007/s10238- -
017- 0479- 9. Epub 2017 Dec 14. PMID: 29243035.
181. Lee I, Zickuhr L, Hassman L.Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine. Curr
Opin Ophthalmol. 2021;32(6):583–9. https://doi.
org/10.1097/ICU.0000000000000810. PMID:
34545846.
182. Aronson AJ, Ordoñez NG, Diddie KR, Ernest
JT.Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med.
1979;139(11):1312–3. PMID: 159674.
183. Chin D, Gan NY, Holder GE, Tien M, Agrawal R,
Manghani M. Severe retinal vasculitis in systemic
lupus erythematosus leading to vision threatening paracentral acute middle maculopathy. Mod
Rheumatol Case Rep. 2021;5(2):265–71. https://doi.
org/10.1080/24725625.2021.1893961. Epub 2021
Mar 15. PMID: 33627049.
184. Stafford-Brady FJ, Urowitz MB, Gladman DD,
Easterbrook M. Lupus retinopathy. Patterns,
266
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
associations, and prognosis. Arthritis Rheum.
1988;31(9):1105–10. https://doi.org/10.1002/
art.1780310904. PMID: 3422014.
185. Edouard S, Douat J, Sailler L, Arlet P, Astudillo
L.Bilateral choroidopathy in systemic lupus erythematosus. Lupus. 2011;20(11):1209–10. https://doi.
org/10.1177/0961203311398510. Epub 2011 Apr
21. PMID: 21511760.
186. Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks
DN, Foster CS. Choroidopathy of systemic lupus
erythematosus. Lupus. 2000;9(4):288–98. https://
doi.org/10.1191/096120300680199024. PMID:
10866100.
187. Hasanreisoglu M, Gulpinar Ikiz GD, Kucuk H,
Varan O, Ozdek S. Acute lupus choroidopathy:
multimodal imaging and differential diagnosis from
central serous chorioretinopathy. Int Ophthalmol.
2018;38(1):369–74. https://doi.org/10.1007/s10792- -
016- 0433- y. Epub 2017 Jan 3. PMID: 28050729.
188. Kucukkomurcu E, Unal AU, Esen F, Ozen G,
Direskeneli H, Kazokoglu H.Ocular posterior segment involvement in patients with antiphospholipid
syndrome and systemic lupus erythematosus. Ocul
Immunol Inamm. 2020;28(1):86–91. https://doi.
org/10.1080/09273948.2018.1552759. Epub 2018
Dec 17. PMID: 30556792.
189. Montehermoso A, Cervera R, Font J, Ramos-Casals
M, García-carrasco M, Formiga F, Callejas JL,
Jorfán M, Griñó MC, Ingelmo M. Association of
antiphospholipid antibodies with retinal vascular
disease in systemic lupus erythematosus. Semin
Arthritis Rheum. 1999;28(5):326–32. https://doi.
org/10.1016/s0049- 0172(99)80017- 1. PMID:
10342390.
190. Aringer M, Costenbader K, Daikh D, Brinks R,
Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy
D, Boumpas DT, Kamen DL, Jayne D, Cervera R,
Costedoat-Chalumeau N, Diamond B, Gladman DD,
Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K,
Massarotti E, McCune J, Ruiz-Irastorza G, SanchezGuerrero J, Schneider M, Urowitz M, Bertsias G,
Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma
Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke
AE, Crow MK, Czirják L, Doria A, Graninger
W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M,
Kumánovics G, Mariette X, Padjen I, Pego-Reigosa
JM, Romero-Diaz J, Rúa-Figueroa Fernández Í,
Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG,
Vasconcelos C, Vital EM, Wallace DJ, Yavuz S,
Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson
SR. 2019 European League Against Rheumatism/
American College of Rheumatology classication
criteria for systemic lupus erythematosus. Arthritis
Rheumatol. 2019;71(9):1400–12. https://doi.
org/10.1002/art.40930. Epub 2019 Aug 6. PMID:
31385462; PMCID: PMC6827566.
191. Costabel U, Hunninghake GW. ATS/ERS/WASOG
statement on sarcoidosis. Sarcoidosis Statement
Committee. American Thoracic Society. European
Respiratory Society. World Association for
Sarcoidosis and Other Granulomatous Disorders.
Eur Respir J. 1999;14(4):735–7. https://doi.
org/10.1034/j.1399- 3003.1999.14d02.x. PMID:
10573213.
192. Korsten P, Tampe B, Konig MF, Nikiphorou
E. Sarcoidosis and autoimmune diseases: differences, similarities and overlaps. Curr Opin Pulm
Med. 2018;24(5):504–12. https://doi.org/10.1097/
MCP.0000000000000500. PMID: 29985181.
193. Niederer RL, Ma SP, Wilsher ML, Ali NQ, Sims JL,
Tomkins-Netzer O, Lightman SL, Lim LL.Systemic
associations of sarcoid uveitis: correlation with
uveitis phenotype and ethnicity. Am J Ophthalmol.
2021;229:169–75. https://doi.org/10.1016/j.
ajo.2021.03.003. Epub 2021 Mar 15. PMID:
33737030.
194. Kassa E, Elner VM, Moroi SE, Sun Y.Diffuse Berlin
nodules: unusual presentation of ocular sarcoidosis. Br J Ophthalmol. 2013;97(9):1214, 1223–4.
Epub 2013 May 31. PMID: 23728905. https://doi.
org/10.1136/bjophthalmol- 2013- 303112.
195. Mahendradas P, Thomas R, Kawali A, Shetty
BK. Berlin nodule in sarcoidosis. Indian J
Ophthalmol. 2019;67(7):1180. https://doi.
org/10.4103/ijo.IJO_1756_18. PMID: 31238450;
PMCID: PMC6611251.
196. Takayama K, Harimoto K, Sato T, Sakurai Y, Taguchi
M, Kanda T, Takeuchi M. Age-related differences
in the clinical features of ocular sarcoidosis. PLoS
One. 2018;13(8):e0202585. https://doi.org/10.1371/
journal.pone.0202585. PMID: 30138345; PMCID:
PMC6107189.
197. Vrabec TR, Augsburger JJ, Fischer DH, Belmont
JB, Tashayyod D, Israel HL. Taches de bougie.
Ophthalmology. 1995;102(11):1712–21. https://
doi.org/10.1016/s0161- 6420(95)30804- 4. PMID:
9098267.
198. Rothova A, Lardenoye C. Arterial macroaneurysms in peripheral multifocal chorioretinitis associated with sarcoidosis. Ophthalmology.
1998;105(8):1393–7. https://doi.org/10.1016/
S0161- 6420(98)98018- 6. PMID: 9709748.
199. Yamanaka E, Ohguro N, Kubota A, Yamamoto
S, Nakagawa Y, Tano Y. Features of retinal arterial macroaneurysms in patients with uveitis. Br
J Ophthalmol. 2004;88(7):884–6. https://doi.
org/10.1136/bjo.2003.035923. PMID: 15205230;
PMCID: PMC1772231.
200. Gass JD, Olson CL. Sarcoidosis with optic nerve
and retinal involvement. A clinicopathologic case
report. Trans Am Acad Ophthalmol Otolaryngol.
1973;77(6):OP739–50. PMID: 4772534.
201. Mehta H, Sim DA, Keane PA, Zarranz-Ventura
J, Gallagher K, Egan CA, Westcott M, Lee RW,
Tufail A, Pavesio CE. Structural changes of the
choroid in sarcoid- and tuberculosis-related granulomatous uveitis. Eye (Lond). 2015;29(8):1060–
8. https://doi.org/10.1038/eye.2015.65. Epub
2015 May 29. PMID: 26021867; PMCID:
PMC4541349.
References
https://t.me/medicina_free
267
202. Pichi F, Invernizzi A, Tucker WR, Munk MR.Optical
coherence tomography diagnostic signs in posterior uveitis. Prog Retin Eye Res. 2020;75:100797.
https://doi.org/10.1016/j.preteyeres.2019.100797.
Epub 2019 Sep 9. PMID: 31513851.
203. Herbort CP, Rao NA, Mochizuki M, Members
of Scientic Committee of First International
Workshop on ocular sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of
the rst international workshop on ocular sarcoidosis
(IWOS). Ocul Immunol Inamm. 2009;17(3):160–
9. https://doi.org/10.1080/09273940902818861.
PMID: 19585358.
204. Acharya NR, Browne EN, Rao N, Mochizuki
M, International Ocular Sarcoidosis Working
Group. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients.
Ophthalmology. 2018;125(1):119–26. https://doi.
org/10.1016/j.ophtha.2017.07.006. Epub 2017 Aug
16. PMID: 28823384.
205. Agarwal R, Srinivasan A, Aggarwal AN, Gupta
D. Efcacy and safety of convex probe EBUSTBNA in sarcoidosis: a systematic review and metaanalysis. Respir Med. 2012;106(6):883–92. https://
doi.org/10.1016/j.rmed.2012.02.014. Epub 2012
Mar 13. PMID: 22417738.
206. Mochizuki M, Smith JR, Takase H, Kaburaki T,
Acharya NR, Rao NA, International Workshop on
Ocular Sarcoidosis Study Group. Revised criteria
of international workshop on ocular sarcoidosis
(IWOS) for the diagnosis of ocular sarcoidosis. Br
J Ophthalmol. 2019;103(10):1418–22. https://doi.
org/10.1136/bjophthalmol- 2018- 313356. Epub 2019
Feb 23. PMID: 30798264.
207. Sakane T, Takeno M, Suzuki N, Inaba G.Behçet’s
disease. N Engl J Med. 1999;341(17):1284–91.
https://doi.org/10.1056/NEJM199910213411707.
PMID: 10528040.
208. Verity DH, Wallace GR, Vaughan RW, Stanford
MR.Behçet’s disease: from Hippocrates to the third
millennium. Br J Ophthalmol. 2003;87(9):1175–
83. https://doi.org/10.1136/bjo.87.9.1175. PMID:
12928293; PMCID: PMC1771837.
209. Poon W, Verity DH, Larkin GL, Graham EM,
Stanford MR. Behçet’s disease in patients of
west African and Afro-Caribbean origin. Br
J Ophthalmol. 2003;87(7):876–8. https://doi.
org/10.1136/bjo.87.7.876. PMID: 12812890;
PMCID: PMC1771753.
210. Takeno M. The association of Behçet’s syndrome
with HLA-B51 as understood in 2021. Curr Opin
Rheumatol. 2022;34(1):4–9. https://doi.org/10.1097/
BOR.0000000000000846. PMID: 34690278;
PMCID: PMC8635258.
211. Gül A, Ozbek U, Oztürk C, Inanç M, Koniçe M,
Ozçelik T. Coagulation factor V gene mutation
increases the risk of venous thrombosis in Behçet’s
disease. Br J Rheumatol. 1996;35(11):1178–80.
https://doi.org/10.1093/rheumatology/35.11.1178.
PMID: 8948311.
212. Ames PR, Steuer A, Pap A, Denman AM.Thrombosis
in Behçet’s disease: a retrospective survey from
a single UK centre. Rheumatology (Oxford).
2001;40(6):652–5. https://doi.org/10.1093/rheuma-
tology/40.6.652. PMID: 11426022.
213. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik
AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P,
Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D,
Salvarani C, Scuderi F, Skakis PP, Siva A, Stanford
M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I,
Yazici H. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome.
Ann Rheum Dis. 2018;77(6):808–18. https://doi.
org/10.1136/annrheumdis- 2018- 213225. Epub 2018
Apr 6. PMID: 29625968.
214. Yazici H, Ugurlu S, Seyahi E. Behçet syndrome:
is it one condition? Clin Rev Allergy Immunol.
2012;43(3):275–80.
012- 8319- x. PMID: 22674015.
215. Sachdev N, Kapali N, Singh R, Gupta V, Gupta
A.Spectrum of Behçet’s disease in the Indian population. Int Ophthalmol. 2009;29(6):495–501. https://
doi.org/10.1007/s10792- 008- 9273- 8. Epub 2008
Oct 21. PMID: 18936879.
216. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin
Altunbas H, Urgancioglu M.Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol.
2004;138(3):373–80. https://doi.org/10.1016/j.
ajo.2004.03.022. PMID: 15364218.
217. Tugal-Tutkun I. Imaging in the diagnosis and
management of Behçet disease. Int Ophthalmol
Clin. 2012;52(4):183–90. https://doi.org/10.1097/
IIO.0b013e318265d56a. PMID: 22954940.
218. Kim BH, Park UC, Park SW, Yu HG.Ultra-Wideeld
uorescein angiography to monitor therapeutic
response to adalimumab in Behcet’s uveitis. Ocul
Immunol Inamm. 2022;30:1347–53. https://doi.org
/10.1080/09273948.2021.1872652. Epub ahead of
print. PMID: 33793368.
219. Yalçındağ FN, Temel E, Şekkeli MZ, Kar İ. Macular
structural changes and factors affecting nal visual
acuity in patients with Behçet uveitis. Graefes Arch
Clin Exp Ophthalmol. 2021;259(3):715–21. https://
doi.org/10.1007/s00417- 020- 04958- 4. Epub 2020
Oct 10. PMID: 33037921.
220. Ji KB, Hu Z, Zhang QL, Mei HF, Xing YQ.Retinal
microvasculature features in patients with Behcet’s
disease: a systematic review and meta-analysis.
Sci Rep. 2022;12(1):752. https://doi.org/10.1038/
s41598- 021- 04730- 6. PMID: 35031636; PMCID:
PMC8760269.
221. International Study Group for Behçet’s Disease.
Criteria for diagnosis of Behçet’s disease. Lancet.
1990;335(8697):1078–80. PMID: 1970380.
222. Tugal-Tutkun I. Uveitis in Behçet disease—an
update. Curr Opin Rheumatol. 2023;35:17. https://
doi.org/10.1097/BOR.0000000000000911. Epub
ahead of print. PMID: 36255985.
223. Akiyama M, Kaneko Y, Takeuchi T. Effectiveness
of tocilizumab in Behcet’s disease: a system-
https://doi.org/10.1007/s12016- -
268
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
atic literature review. Semin Arthritis Rheum.
2020;50(4):797–804. https://doi.org/10.1016/j.
semarthrit.2020.05.017. Epub 2020 Jun 5. PMID:
32544751.
224. Zou J, Lin CH, Wang Y, Shen Y, Guan
JL. Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’. Ann
Rheum Dis. 2023;82:e100. https://doi.org/10.1136/
annrheumdis- 2020- 219810. Epub ahead of print.
PMID: 33495153.
225. Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford
MR, Chams H. Ocular features of Behcet’s disease: an international collaborative study. Br J
Ophthalmol. 2007;91(12):1579–82. https://doi.
org/10.1136/bjo.2007.123554. PMID: 18024808;
PMCID: PMC2095523.
226. Read RW, Holland GN, Rao NA, Tabbara KF,
Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler
HH, Usui M.Revised diagnostic criteria for VogtKoyanagi- Harada disease: report of an international
committee on nomenclature. Am J Ophthalmol.
2001;131(5):647–52. https://doi.org/10.1016/s0002- -
9394(01)00925- 4. PMID: 11336942.
227. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi
S. Tyrosinase family proteins are antigens specic
to Vogt-Koyanagi-Harada disease. J Immunol.
2000;165(12):7323–9. https://doi.org/10.4049/jim-
munol.165.12.7323. PMID: 11120868.
228. Yamaki K, Kondo I, Nakamura H, Miyano M,
Konno S, Sakuragi S. Ocular and extraocular
inammation induced by immunization of tyrosinase related protein 1 and 2in Lewis rats. Exp Eye
Res. 2000;71(4):361–9. https://doi.org/10.1006/
exer.2000.0893. PMID: 10995557.
229. Okada T, Sakamoto T, Ishibashi T, Inomata
H.Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inammatory site. Graefes
Arch Clin Exp Ophthalmol. 1996;234(6):359–63.
https://doi.org/10.1007/BF00190711. PMID:
8738701.
230. O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017;62(1):1–25. https://
doi.org/10.1016/j.survophthal.2016.05.002. Epub
2016 May 27. PMID: 27241814.
231. Rathinam SR, Namperumalsamy P, Nozik RA,
Cunningham ET Jr. Vogt-Koyanagi-Harada syndrome after cutaneous injury. Ophthalmology.
1999;106(3):635–8. https://doi.org/10.1016/S0161- -
6420(99)90129- X. PMID: 10080227.
232. Lim JA, Tan WC, Nor NM. Hints from the skin
beneath: Vitiligo in Vogt–Koyanagi–Harada disease.
Dermatol Sin [serial online]. 2022 [cited 2022 Oct
31];40:78–84. https://www.dermsinica.org/text.
asp?2022/40/2/78/347097.
233. Anthony E, Rajamani A, Baskaran P, Rajendran
A. Vogt Koyanagi Harada disease following a
recent COVID-19 infection. Indian J Ophthalmol.
2022;70(2):670–2. https://doi.org/10.4103/
ijo.IJO_2550_21. PMID: 35086262; PMCID:
PMC9023905.
234. Chen X, Wang B, Li X.Acute-onset Vogt-KoyanagiHarada like uveitis following Covid-19 inactivated virus vaccination. Am J Ophthalmol Case
Rep. 2022;26:101404. https://doi.org/10.1016/j.
ajoc.2022.101404. Epub 2022 Feb 9. PMID:
35165663; PMCID: PMC8826601.
235. De Domingo B, López M, Lopez-Valladares M,
Ortegon-Aguilar E, Sopeña-Perez-Argüelles B,
Gonzalez F. Vogt-Koyanagi-Harada disease exacerbation associated with COVID-19 vaccine.
Cells. 2022;11(6):1012. https://doi.org/10.3390/
cells11061012. PMID: 35326462; PMCID:
PMC8947156.
236. Gambichler T, Seifert C, Lehmann M, Lukas C,
Scheel C, Susok L. Concurrent Vogt-KoyanagiHarada disease and impressive response to immune
checkpoint blockade in metastatic melanoma.
Immunotherapy. 2020;12(7):439–44. https://doi.
org/10.2217/imt- 2019- 0206. Epub 2020 Apr 19.
PMID: 32308086.
237. Rao NA, Gupta A, Dustin L, Chee SP, Okada AA,
Khairallah M, Bodaghi B, Lehoang P, Accorinti
M, Mochizuki M, Prabriputaloong T, Read
RW. Frequency of distinguishing clinical features
in Vogt-Koyanagi-Harada disease. Ophthalmology.
2010;117(3):591–9, 599.e1. Epub 2009 Dec 24.
PMID: 20036008; PMCID: PMC2830365. https://
doi.org/10.1016/j.ophtha.2009.08.030.
238. Ohno S, Minakawa R, Matsuda H.Clinical studies of
Vogt-Koyanagi-Harada’s disease. Jpn J Ophthalmol.
1988;32(3):334–43. PMID: 3230720.
239. Herbort CP, Mantovani A, Bouchenaki
N. Indocyanine green angiography in VogtKoyanagi- Harada disease: angiographic signs
and utility in patient follow-up. Int Ophthalmol.
2007;27(2–3):173–82. https://doi.org/10.1007/
s10792- 007- 9060- y. Epub 2007 Apr 25. PMID:
17457515.
240. Silpa-Archa S, Ittharat W, Chotcomwongse P, Preble
JM, Foster CS.Analysis of three-dimensional choroidal volume with enhanced depth imaging ndings
in patients with recurrent Vogt-Koyanagi-Harada
disease. Curr Eye Res. 2021;46(7):1010–7. https://
doi.org/10.1080/02713683.2020.1849732. Epub
2020 Nov 20. PMID: 33215546.
241. Gupta V, Gupta A, Gupta P, Sharma A. Spectraldomain cirrus optical coherence tomography of
choroidal striations seen in the acute stage of
Vogt-Koyanagi-Harada disease. Am J Ophthalmol.
2009;147(1):148–153.e2. https://doi.org/10.1016/j.
ajo.2008.07.028. Epub 2008 Oct 2. PMID:
18834577.
242. Kuo IC, Rechdouni A, Rao NA, Johnston RH,
Margolis TP, Cunningham ET Jr. Subretinal brosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology. 2000;107(9):1721–8. https://
doi.org/10.1016/s0161- 6420(00)00244- x. PMID:
10964836.
243. Kilmartin DJ, Dick AD, Forrester JV.Prospective
surveillance of sympathetic ophthalmia in the
Соседние файлы в папке Библиотека им академика М.И. Перельмана